HOPKINTON, Mass., Feb. 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. , a leading provider of tools and services for drug discovery and life sciences research, today introduced the LabChip XT, an automated nucleic acid fractionation instrument. The solution removes a key bottleneck in the current workflow for next generation sequencing by replacing the tedious gel isolation and purification steps used for size selection of sheared genomic DNA. The LabChip XT and its integrated software utilize a multi-channel microfluidic chip to quickly process samples independently and without the potential for cross contamination.
The LabChip XT will be presented at the 2010 Advances in Genome Biology and Technology (AGBT) conference, February 24( )- 27 in Marco Island, Florida. For additional information on the LabChip XT or to learn more about the XT Early Access Program, please visit Caliper at AGBT or www.caliperls.com.
Caliper and LabChip are registered trademarks of Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc.
